Women's Hospital School Of Medicine Zhejiang University
Clinical trials sponsored by Women's Hospital School Of Medicine Zhejiang University, explained in plain language.
-
New immunotherapy may let some women skip surgery for endometrial cancer
Disease control Not yet recruitingThis study tests whether a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) can shrink or eliminate tumors in women with a specific type of endometrial cancer (mismatch repair-deficient). The goal is to see if these drugs can be an alternative to surgery. Abo…
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated May 26, 2026 11:55 UTC
-
New drug combo shows promise in High-Risk cervical cancer trial
Disease control Not yet recruitingThis study tests whether adding the drug ivonescimab to standard chemotherapy before chemoradiotherapy can help control high-risk cervical cancer that has spread locally. About 42 women with stage III to IVA cervical cancer will receive two cycles of the combination, then standar…
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated May 19, 2026 11:46 UTC